Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through two segments: Proteomics and Genomics. It provides SomaScan platform that enables researchers to measure thousands of proteins simultaneously, providing deep insights into biological processes and disease mechanism; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system redefines high-throughput genomics by delivering exceptional efficiency, precision, and scalability for qPCR applications. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Standard BioTools Inc.

Astera Labs, Inc. ( ($ALAB) ) has risen by 7.01%. Read on to learn why. Astera Labs, Inc. shares gained 7.01% over the past week, reflecting strong...

Astera Labs, Inc. Extends AI Surge Despite Risks

An announcement from Genomma Lab Internacional SAB de CV ( ($MX:LABB) ) is now available. Genomma Lab Internacional, a major Mexican pharmaceutical...

Genomma Lab Sets Seventeenth Dividend, Reaffirms Quarterly Payout Strategy

In a report released on September 15, from UBS maintained a Buy rating on Zai Lab Ltd, with a price target of HK$27.00. The company’s shares closed...

Zai Lab Ltd (1ZLB) Receives a Buy from UBS

Labrador Gold Corp ( ($TSE:LAB) ) has shared an announcement. Labrador Gold Corp. plans to raise between $2 million and $4 million through a non-br...

Labrador Gold Launches Up to $4 Million Financing and Names New President

Susquehanna analyst Mehdi Hosseini maintained a Hold rating on Astera Labs, Inc. on September 12 and set a price target of $310.00. Hosseini covers...

Astera Labs, Inc. (ALAB) Gets a Hold from Susquehanna

Mesa Laboratories ( ($MLAB) ) just unveiled an announcement. On September 8, 2026, Mesa Laboratories held its annual meeting of shareholders, with ...

Mesa Laboratories Shareholders Back Board And Governance Decisions

In a report released on September 5, Mehdi Hosseini from Susquehanna maintained a Hold rating on Astera Labs, Inc., with a price target of $310.00....

Astera Labs, Inc. (ALAB) Receives a Rating Update from a Top Analyst

Shares of Astera Labs (ALAB) and Bloom Energy ($BE) rose about 11% and 7% on Friday. The move comes as traders bet both companies could be added to...

Astera Labs (ALAB) and Bloom Energy (BE) Soar as Investors Bet on S&P 500 Index (SPX) Inclusion

PMGC Holdings ( ($ELAB) ) just unveiled an announcement. On August 27, 2026, NorthStrive Biosciences, a wholly owned subsidiary of PMGC Holdings, e...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LAB	$0.74	-0.42%	471.80K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LAB	$0.74	-0.4%	471.80K
3
4
5
6

LAB

Get Standard BioTools Inc. Data in Excel

Get Standard BioTools Inc. Data in Excel